Dr. Schellhammer has "Cracked the Mystery of Humanity"

Individuation Academy poised to help 50 million over the coming decade and supply new hope around the globe.

2010-10-28

MARBELLA, SPAIN, October 28, 2010 (Press-News.org) Despite the advances humankind has made in technology, science, communication and spirituality over the past thousand years, human beings have yet to solve the most important, intriguing mysteries of humanity.

What is the meaning of life? Is there a God? Why is there suffering and death? What happens when I die? Who am I? Every day across the globe, billions of people are asking these questions, left unsatisfied with the answers.

Dr. Edward Schellhammer's Individuation Academy aims to form life counselors and coaches for the Third Millennium. "We intend to provide personal and spiritual fulfillment to billions, through democratic and dogma-free education that answers the most important questions in life," says Schellhammer. "The Individuation Academy will also supply a new career niche that can potentially provide stability and purpose to 50, if not 100, million people in the coming decade."

The world's population today faces a future of financial instability, economic turmoil, social unrest, wars, and a lack of realistic and long-term job perspectives. "Life coaches and counselors who offer real support and guidance to people all over the world have never been more needed than they are today," says Schellhammer, "and we intend to fill this need."

Dr. Schellhammer has authored 21 books and founded Marbella University. He studied education, psychology, philosophy, information technology and statistics in Fribourg and Zurich. He has expertise in psychoanalysis, humanistic psychology, and behavior training.

It's no secret that every day, billions of people ask questions about life, love, relationships, spirituality, sexuality, dreams, feelings and inner conflicts. Dr. Schellhammer insists that "the programs provided by the Individuation Academy are founded in the Archetypes of the Soul and offer the answers, tools, skills, and environment for developing the 'cracked mystery of humanity.'" It is the doctor's hope to offer billions of people a peaceful future in an evolutionary age. He seems well-equipped to begin this challenging new venture.

For more information about educational programs, insights, and services offered by the Individuation Academy, visit their website at http://www.individuationacademy.com or call (+34) 952.810.645.

ELSE PRESS RELEASES FROM THIS DATE:

Alliance Benefit Group Receives Industry Award

2010-10-28

Alliance Benefit Group, LLC (ABG) received an Excellence in Communications award at the recent annual meeting for the Retirement Income Industry Association (RIIA). The RIIA annually selects what they deem as the communications materials, advertising and marketing initiatives that stand out across the retirement income industry. ABG was named the winner of the Retail Retirement Income Communications Award sponsored by Investment News in the category of New Media. ABG earned the award for its submission of "Introducing a Smarter Way to Manage Your 401(k) Plan", a campaign ...

3D From Your Camera: Eos Systems Announces PhotoModeler 2010

2010-10-28

Eos Systems today announced the release of PhotoModeler 2010 and PhotoModeler Scanner 2010. PhotoModeler, a Windows application, is used to create 3D models and measurements from photographs using ordinary digital cameras. PhotoModeler Scanner software adds the capability of creating dense point clouds like a laser or 3D scanner but eliminates the need for expensive and cumbersome equipment. The flexibility in using the ubiquitous digital camera offers sophisticated 3D capabilities for technical professionals and home users alike. Both ends of this user spectrum ...

New guideline from ASH and ASCO recommends caution regarding ESA use in cancer patients

2010-10-27

(WASHINGTON, October 25, 2010) – An updated joint guideline by the American Society of Hematology (ASH) and the American Society of Clinical Oncology (ASCO) advises physicians about the appropriate use of erythropoiesis-stimulating agents (ESAs), a class of drugs that stimulate the bone marrow to produce more red blood cells, to treat cancer patients with chemotherapy-induced anemia. While the guideline cautions that ESAs are associated with shorter survival and increased risk of thromboembolism — blood clots — and tumor progression, it also recognizes their major benefit ...

New class of biomolecules triggered in response to respiratory virus infection

2010-10-27

For the first time, scientists have discovered that a poorly understood class of RNA produced in a mammal's cells during a respiratory virus attack may affect the outcome of the infection. Their findings are reported today in mBio, a journal of the American Society for Microbiology. RNA (ribonucleic acid) contains information transcribed from the cell's instruction manual, its DNA. The best known of these RNAs translate sections of DNA code into building blocks for proteins. Most studies of how animals' cells respond to virus infection typically look at protein-coding ...

Landmark study finds high resting heart associated with shorter life expectancy

2010-10-27

Montreal −If you are a person who already has stable heart disease, how fast your heart beats at rest can predict your risk of dying, not only from heart disease but all other causes, Dr. Eva Lonn told the Canadian Cardiovascular Congress 2010, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society. "The higher the heart rate, the higher the risk of death from cardiovascular and all causes, even after adjusting for all risk factors that could confound our results," says Dr. Lonn, a cardiologist and professor at McMaster University. ...

Severe sepsis associated with development of cognitive and functional disability in older patients

2010-10-27

Older adults who survived severe sepsis were more likely to develop substantial cognitive impairment and functional disability, according to a study in the October 27 issue of JAMA. Hundreds of thousands of patients endure severe sepsis each year in the United States, according to background information in the article. "Although severe sepsis is the most common non-cardiac cause of critical illness, the long-term impact of severe sepsis on cognitive and physical functioning is unknown," the authors write. Theodore J. Iwashyna, M.D., Ph.D., of the University of Michigan ...

Patients who survive sepsis are more than 3 times as likely to have cognitive problems

2010-10-27

Ann Arbor, Mich. — Older adults who survive severe sepsis are at higher risk for long-term cognitive impairment and physical limitations than those hospitalized for other reasons, according to researchers from the University of Michigan Health System. Research to be published Oct. 27 in the Journal of the American Medical Association showed that 60 percent of hospitalizations for severe sepsis were associated with worsened cognitive and physical function among surviving older adults. The odds of acquiring moderate to severe cognitive impairment were 3.3 times higher ...

Colorectal cancer patients with gene mutation show better response to cancer agent

2010-10-27

Even though the cancer-treatment agent cetuximab is not considered effective treatment for KRAS (a gene)-mutated metastatic colorectal tumors, new research indicates that patients with colorectal cancer not responding to chemotherapy and a certain variation of this gene who were treated with cetuximab had longer overall and progression-free survival than patients with other KRAS-mutations, according to a study in the October 27 issue of JAMA. "Recent retrospective correlative analyses of metastatic colorectal cancer trials indicate that patients with KRAS-mutated tumors ...

2 clinical trials demonstrate effective weight loss strategies for obese and overweight adults

2010-10-27

Lifestyle interventions, including physical activity and structured weight loss programs, can result in significant weight loss for overweight, obese and severely obese adults, according to two reports that were posted online October 9 by JAMA. The studies and accompanying editorials were made available early online to coincide with the presentation of these papers at the 28th Annual Scientific Meeting of the Obesity Society. The articles appear in the October 27 print issue of JAMA. According to background information in the papers, obesity is among the most significant ...

Genetic variations linked with worse outcomes with use of antiplatelet drug for cardiac procedures

2010-10-27

An analysis of data from previously published studies indicates that use of the antiplatelet drug clopidogrel for patients who have common genetic variants of a certain gene and are undergoing a procedure such as coronary stent placement have an associated increased risk for major adverse cardiovascular events, particularly development of blood clots in stents, according to a study in the October 27 issue of JAMA. Clopidogrel, one of the most commonly prescribed medications, has been shown to reduce cardiovascular events in patients undergoing percutaneous coronary intervention ...

Alliance presents final results from phase III CABINET pivotal trial evaluating cabozantinib in advanced neuroendocrine tumors at ESMO 2024 and published in New England Journal of Medicine

X.J. Meng receives prestigious MERIT Award to study hepatitis E virus

[Press-News.org] Dr. Schellhammer has "Cracked the Mystery of Humanity"
Individuation Academy poised to help 50 million over the coming decade and supply new hope around the globe.

Dr. Schellhammer has "Cracked the Mystery of Humanity"

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: